nodes	percent_of_prediction	percent_of_DWPC	metapath
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—TMEFF2—polycystic ovary syndrome	0.0369	0.125	CbGpPWpGaD
Azacitidine—DNMT3A—embryo—polycystic ovary syndrome	0.0366	0.0871	CbGeAlD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—ANLN—polycystic ovary syndrome	0.0254	0.0861	CbGpPWpGaD
Azacitidine—CDA—endometrium—polycystic ovary syndrome	0.0253	0.0602	CbGeAlD
Azacitidine—DNMT3A—pituitary gland—polycystic ovary syndrome	0.0242	0.0576	CbGeAlD
Azacitidine—DNMT3A—adipose tissue—polycystic ovary syndrome	0.0241	0.0574	CbGeAlD
Azacitidine—CDA—adipose tissue—polycystic ovary syndrome	0.0228	0.0543	CbGeAlD
Azacitidine—DNMT1—embryo—polycystic ovary syndrome	0.0221	0.0527	CbGeAlD
Azacitidine—DNMT3A—adrenal gland—polycystic ovary syndrome	0.0217	0.0515	CbGeAlD
Azacitidine—CDA—adrenal gland—polycystic ovary syndrome	0.0205	0.0487	CbGeAlD
Azacitidine—DNMT3A—female gonad—polycystic ovary syndrome	0.0202	0.048	CbGeAlD
Azacitidine—DNMT3A—vagina—polycystic ovary syndrome	0.0201	0.0477	CbGeAlD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TTK—polycystic ovary syndrome	0.0193	0.0653	CbGpPWpGaD
Azacitidine—CDA—vagina—polycystic ovary syndrome	0.019	0.0451	CbGeAlD
Azacitidine—DNMT3A—endocrine gland—polycystic ovary syndrome	0.0188	0.0447	CbGeAlD
Azacitidine—DNMT1—adrenal cortex—polycystic ovary syndrome	0.0181	0.0431	CbGeAlD
Azacitidine—CDA—endocrine gland—polycystic ovary syndrome	0.0177	0.0422	CbGeAlD
Azacitidine—DNMT1—endometrium—polycystic ovary syndrome	0.0162	0.0385	CbGeAlD
Azacitidine—CDA—Fluoropyrimidine Activity—RRM2—polycystic ovary syndrome	0.0161	0.0547	CbGpPWpGaD
Azacitidine—DNMT1—uterus—polycystic ovary syndrome	0.0149	0.0355	CbGeAlD
Azacitidine—DNMT1—pituitary gland—polycystic ovary syndrome	0.0147	0.0349	CbGeAlD
Azacitidine—DNMT1—adipose tissue—polycystic ovary syndrome	0.0146	0.0347	CbGeAlD
Azacitidine—DNMT3A—Epigenetic regulation of gene expression—SAP30L—polycystic ovary syndrome	0.014	0.0475	CbGpPWpGaD
Azacitidine—Loose stools—Metformin—polycystic ovary syndrome	0.0139	0.0531	CcSEcCtD
Azacitidine—DNMT1—adrenal gland—polycystic ovary syndrome	0.0131	0.0311	CbGeAlD
Azacitidine—DNMT1—female gonad—polycystic ovary syndrome	0.0122	0.029	CbGeAlD
Azacitidine—DNMT1—vagina—polycystic ovary syndrome	0.0121	0.0289	CbGeAlD
Azacitidine—Respiratory distress—Metformin—polycystic ovary syndrome	0.0121	0.0463	CcSEcCtD
Azacitidine—DNMT1—endocrine gland—polycystic ovary syndrome	0.0114	0.027	CbGeAlD
Azacitidine—DNMT1—NoRC negatively regulates rRNA expression—SAP30L—polycystic ovary syndrome	0.0109	0.037	CbGpPWpGaD
Azacitidine—DNMT1—Negative epigenetic regulation of rRNA expression—SAP30L—polycystic ovary syndrome	0.0107	0.0362	CbGpPWpGaD
Azacitidine—DNMT3A—One Carbon Metabolism—MTHFR—polycystic ovary syndrome	0.0097	0.0329	CbGpPWpGaD
Azacitidine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00949	0.0363	CcSEcCtD
Azacitidine—DNMT1—Epigenetic regulation of gene expression—SAP30L—polycystic ovary syndrome	0.00947	0.0321	CbGpPWpGaD
Azacitidine—Rigors—Metformin—polycystic ovary syndrome	0.00942	0.036	CcSEcCtD
Azacitidine—Clofarabine—RRM2—polycystic ovary syndrome	0.00933	0.402	CrCbGaD
Azacitidine—DNMT3A—Chromatin modifying enzymes—SAP30L—polycystic ovary syndrome	0.00884	0.03	CbGpPWpGaD
Azacitidine—Contusion—Metformin—polycystic ovary syndrome	0.00881	0.0337	CcSEcCtD
Azacitidine—DNMT3A—Trans-sulfuration and one carbon metabolism—MTHFR—polycystic ovary syndrome	0.00872	0.0295	CbGpPWpGaD
Azacitidine—Gemcitabine—RRM2—polycystic ovary syndrome	0.00854	0.367	CrCbGaD
Azacitidine—CDA—Fluoropyrimidine Activity—MTHFR—polycystic ovary syndrome	0.00815	0.0276	CbGpPWpGaD
Azacitidine—CDA—Nucleotide metabolism—RRM2—polycystic ovary syndrome	0.0081	0.0275	CbGpPWpGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCNE2—polycystic ovary syndrome	0.00713	0.0242	CbGpPWpGaD
Azacitidine—DNMT1—One Carbon Metabolism—MTHFR—polycystic ovary syndrome	0.00655	0.0222	CbGpPWpGaD
Azacitidine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00613	0.0234	CcSEcCtD
Azacitidine—DNMT1—Trans-sulfuration and one carbon metabolism—MTHFR—polycystic ovary syndrome	0.00589	0.02	CbGpPWpGaD
Azacitidine—Lethargy—Metformin—polycystic ovary syndrome	0.0057	0.0218	CcSEcCtD
Azacitidine—Pain in extremity—Metformin—polycystic ovary syndrome	0.00558	0.0214	CcSEcCtD
Azacitidine—Cladribine—RRM2—polycystic ovary syndrome	0.00536	0.231	CrCbGaD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—RRM2—polycystic ovary syndrome	0.00523	0.0177	CbGpPWpGaD
Azacitidine—Dehydration—Metformin—polycystic ovary syndrome	0.00519	0.0199	CcSEcCtD
Azacitidine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.0051	0.0195	CcSEcCtD
Azacitidine—Cramp muscle—Metformin—polycystic ovary syndrome	0.00503	0.0192	CcSEcCtD
Azacitidine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00499	0.0191	CcSEcCtD
Azacitidine—Abdominal distension—Metformin—polycystic ovary syndrome	0.00486	0.0186	CcSEcCtD
Azacitidine—Sweating increased—Metformin—polycystic ovary syndrome	0.0047	0.018	CcSEcCtD
Azacitidine—Neutropenia—Metformin—polycystic ovary syndrome	0.00451	0.0173	CcSEcCtD
Azacitidine—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00448	0.0172	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—TOP2A—polycystic ovary syndrome	0.0044	0.0149	CbGpPWpGaD
Azacitidine—Infestation NOS—Metformin—polycystic ovary syndrome	0.0043	0.0165	CcSEcCtD
Azacitidine—Infestation—Metformin—polycystic ovary syndrome	0.0043	0.0165	CcSEcCtD
Azacitidine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00407	0.0156	CcSEcCtD
Azacitidine—DNMT1—Retinoblastoma (RB) in Cancer—CCNB1—polycystic ovary syndrome	0.00396	0.0134	CbGpPWpGaD
Azacitidine—Rhinitis—Metformin—polycystic ovary syndrome	0.00387	0.0148	CcSEcCtD
Azacitidine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00384	0.0147	CcSEcCtD
Azacitidine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0038	0.0146	CcSEcCtD
Azacitidine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00379	0.0145	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—ZNF205—polycystic ovary syndrome	0.00363	0.0123	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—ZNF430—polycystic ovary syndrome	0.00363	0.0123	CbGpPWpGaD
Azacitidine—Eye disorder—Metformin—polycystic ovary syndrome	0.00361	0.0138	CcSEcCtD
Azacitidine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00358	0.0137	CcSEcCtD
Azacitidine—Angiopathy—Metformin—polycystic ovary syndrome	0.0035	0.0134	CcSEcCtD
Azacitidine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00349	0.0133	CcSEcCtD
Azacitidine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00348	0.0133	CcSEcCtD
Azacitidine—Chills—Metformin—polycystic ovary syndrome	0.00346	0.0133	CcSEcCtD
Azacitidine—DNMT3A—Validated targets of C-MYC transcriptional repression—BCL2—polycystic ovary syndrome	0.0034	0.0115	CbGpPWpGaD
Azacitidine—Erythema—Metformin—polycystic ovary syndrome	0.00336	0.0129	CcSEcCtD
Azacitidine—Malnutrition—Metformin—polycystic ovary syndrome	0.00336	0.0129	CcSEcCtD
Azacitidine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00323	0.0124	CcSEcCtD
Azacitidine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00312	0.0119	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—ADARB1—polycystic ovary syndrome	0.00309	0.0105	CbGpPWpGaD
Azacitidine—Malaise—Metformin—polycystic ovary syndrome	0.00303	0.0116	CcSEcCtD
Azacitidine—Syncope—Metformin—polycystic ovary syndrome	0.00301	0.0115	CcSEcCtD
Azacitidine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00295	0.0113	CcSEcCtD
Azacitidine—Hypertension—Metformin—polycystic ovary syndrome	0.0029	0.0111	CcSEcCtD
Azacitidine—Myalgia—Metformin—polycystic ovary syndrome	0.00286	0.011	CcSEcCtD
Azacitidine—Chest pain—Metformin—polycystic ovary syndrome	0.00286	0.011	CcSEcCtD
Azacitidine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00284	0.0109	CcSEcCtD
Azacitidine—Discomfort—Metformin—polycystic ovary syndrome	0.00283	0.0108	CcSEcCtD
Azacitidine—Oedema—Metformin—polycystic ovary syndrome	0.00274	0.0105	CcSEcCtD
Azacitidine—Infection—Metformin—polycystic ovary syndrome	0.00273	0.0104	CcSEcCtD
Azacitidine—Shock—Metformin—polycystic ovary syndrome	0.0027	0.0103	CcSEcCtD
Azacitidine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00269	0.0103	CcSEcCtD
Azacitidine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00269	0.0103	CcSEcCtD
Azacitidine—DNMT1—Regulation of retinoblastoma protein—PPARG—polycystic ovary syndrome	0.00268	0.00907	CbGpPWpGaD
Azacitidine—Skin disorder—Metformin—polycystic ovary syndrome	0.00266	0.0102	CcSEcCtD
Azacitidine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00265	0.0101	CcSEcCtD
Azacitidine—Anorexia—Metformin—polycystic ovary syndrome	0.00261	0.01	CcSEcCtD
Azacitidine—Hypotension—Metformin—polycystic ovary syndrome	0.00256	0.00981	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—LSM5—polycystic ovary syndrome	0.00252	0.00854	CbGpPWpGaD
Azacitidine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.0025	0.00956	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—ZNF430—polycystic ovary syndrome	0.00246	0.00832	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ZNF205—polycystic ovary syndrome	0.00246	0.00832	CbGpPWpGaD
Azacitidine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00245	0.00936	CcSEcCtD
Azacitidine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00241	0.00924	CcSEcCtD
Azacitidine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00238	0.00913	CcSEcCtD
Azacitidine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00237	0.00906	CcSEcCtD
Azacitidine—Fatigue—Metformin—polycystic ovary syndrome	0.00237	0.00905	CcSEcCtD
Azacitidine—Constipation—Metformin—polycystic ovary syndrome	0.00235	0.00898	CcSEcCtD
Azacitidine—DNMT3A—Gene Expression—SAP30L—polycystic ovary syndrome	0.00234	0.00794	CbGpPWpGaD
Azacitidine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00226	0.00865	CcSEcCtD
Azacitidine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00224	0.00858	CcSEcCtD
Azacitidine—Urticaria—Metformin—polycystic ovary syndrome	0.00218	0.00834	CcSEcCtD
Azacitidine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00217	0.0083	CcSEcCtD
Azacitidine—DNMT3A—Chromatin modifying enzymes—NCOR1—polycystic ovary syndrome	0.00213	0.00723	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—ADARB1—polycystic ovary syndrome	0.00209	0.00708	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NMNAT3—polycystic ovary syndrome	0.00205	0.00696	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—TEAD2—polycystic ovary syndrome	0.00199	0.00675	CbGpPWpGaD
Azacitidine—Asthenia—Metformin—polycystic ovary syndrome	0.00197	0.00753	CcSEcCtD
Azacitidine—Pruritus—Metformin—polycystic ovary syndrome	0.00194	0.00743	CcSEcCtD
Azacitidine—CDA—Metabolism—SUOX—polycystic ovary syndrome	0.00188	0.00637	CbGpPWpGaD
Azacitidine—CDA—Metabolism—LPCAT2—polycystic ovary syndrome	0.00188	0.00637	CbGpPWpGaD
Azacitidine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00188	0.00718	CcSEcCtD
Azacitidine—Dizziness—Metformin—polycystic ovary syndrome	0.00181	0.00694	CcSEcCtD
Azacitidine—CDA—Metabolism—ISYNA1—polycystic ovary syndrome	0.00175	0.00592	CbGpPWpGaD
Azacitidine—Vomiting—Metformin—polycystic ovary syndrome	0.00174	0.00668	CcSEcCtD
Azacitidine—Rash—Metformin—polycystic ovary syndrome	0.00173	0.00662	CcSEcCtD
Azacitidine—Dermatitis—Metformin—polycystic ovary syndrome	0.00173	0.00661	CcSEcCtD
Azacitidine—Headache—Metformin—polycystic ovary syndrome	0.00172	0.00658	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—LSM5—polycystic ovary syndrome	0.0017	0.00577	CbGpPWpGaD
Azacitidine—Nausea—Metformin—polycystic ovary syndrome	0.00163	0.00624	CcSEcCtD
Azacitidine—DNMT1—Gene Expression—SAP30L—polycystic ovary syndrome	0.00158	0.00536	CbGpPWpGaD
Azacitidine—CDA—Metabolism—AKR1C2—polycystic ovary syndrome	0.00148	0.00503	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TEAD2—polycystic ovary syndrome	0.00148	0.00503	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—RPL37A—polycystic ovary syndrome	0.00142	0.00481	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—TEAD2—polycystic ovary syndrome	0.00135	0.00456	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PNPLA2—polycystic ovary syndrome	0.00124	0.00422	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SRD5A1—polycystic ovary syndrome	0.00118	0.004	CbGpPWpGaD
Azacitidine—CDA—Metabolism—STAR—polycystic ovary syndrome	0.00113	0.00381	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HMMR—polycystic ovary syndrome	0.001	0.0034	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—RPL37A—polycystic ovary syndrome	0.000959	0.00325	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HSD3B1—polycystic ovary syndrome	0.000957	0.00324	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—YAP1—polycystic ovary syndrome	0.000952	0.00323	CbGpPWpGaD
Azacitidine—CDA—Metabolism—LHB—polycystic ovary syndrome	0.000872	0.00296	CbGpPWpGaD
Azacitidine—CDA—Metabolism—HSD3B2—polycystic ovary syndrome	0.000853	0.00289	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—TNRC6B—polycystic ovary syndrome	0.00084	0.00285	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PGR—polycystic ovary syndrome	0.000831	0.00282	CbGpPWpGaD
Azacitidine—CDA—Metabolism—AKR1C1—polycystic ovary syndrome	0.000826	0.0028	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SULT2A1—polycystic ovary syndrome	0.00076	0.00258	CbGpPWpGaD
Azacitidine—CDA—Metabolism—RRM2—polycystic ovary syndrome	0.000736	0.0025	CbGpPWpGaD
Azacitidine—CDA—Metabolism—YAP1—polycystic ovary syndrome	0.00071	0.00241	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NAMPT—polycystic ovary syndrome	0.000682	0.00231	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP11A1—polycystic ovary syndrome	0.000673	0.00228	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—AR—polycystic ovary syndrome	0.000646	0.00219	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—YAP1—polycystic ovary syndrome	0.000643	0.00218	CbGpPWpGaD
Azacitidine—CDA—Metabolism—AKR1C3—polycystic ovary syndrome	0.000636	0.00216	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP17A1—polycystic ovary syndrome	0.000626	0.00212	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—TNRC6B—polycystic ovary syndrome	0.000567	0.00192	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NCOR1—polycystic ovary syndrome	0.000565	0.00192	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PGR—polycystic ovary syndrome	0.000561	0.0019	CbGpPWpGaD
Azacitidine—CDA—Metabolism—TH—polycystic ovary syndrome	0.000542	0.00184	CbGpPWpGaD
Azacitidine—CDA—Metabolism—SLC2A4—polycystic ovary syndrome	0.000527	0.00179	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—NR3C1—polycystic ovary syndrome	0.000523	0.00177	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP19A1—polycystic ovary syndrome	0.000495	0.00168	CbGpPWpGaD
Azacitidine—CDA—Metabolism—GNAS—polycystic ovary syndrome	0.000442	0.0015	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—AR—polycystic ovary syndrome	0.000437	0.00148	CbGpPWpGaD
Azacitidine—CDA—Metabolism—NCOR1—polycystic ovary syndrome	0.000421	0.00143	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—PPARG—polycystic ovary syndrome	0.000405	0.00137	CbGpPWpGaD
Azacitidine—CDA—Metabolism—CYP1A1—polycystic ovary syndrome	0.000399	0.00135	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NCOR1—polycystic ovary syndrome	0.000382	0.00129	CbGpPWpGaD
Azacitidine—CDA—Metabolism—MTHFR—polycystic ovary syndrome	0.000372	0.00126	CbGpPWpGaD
Azacitidine—DNMT3A—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000365	0.00124	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—NR3C1—polycystic ovary syndrome	0.000353	0.0012	CbGpPWpGaD
Azacitidine—CDA—Metabolism—PPARG—polycystic ovary syndrome	0.000302	0.00102	CbGpPWpGaD
Azacitidine—CDA—Metabolism—POMC—polycystic ovary syndrome	0.000298	0.00101	CbGpPWpGaD
Azacitidine—CDA—Metabolism—INS—polycystic ovary syndrome	0.000296	0.001	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—PPARG—polycystic ovary syndrome	0.000273	0.000927	CbGpPWpGaD
Azacitidine—DNMT1—Gene Expression—SERPINE1—polycystic ovary syndrome	0.000246	0.000835	CbGpPWpGaD
